Figure 3From: Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trialsClinical outcome for node negative patients aged less than 40 years stratified by pathological tumor size. A, Overall survival. B, Distant disease-free survival.Back to article page